Product
ChAd63-KH
1 clinical trial
2 indications
Indication
LeishmaniasisIndication
CutaneousClinical trial
A Phase IIb Study to Assess the Safety, Efficacy and Immunogenicity of the Leishmania Vaccine ChAd63-KH in Post-kala Azar Dermal LeishmaniasisStatus: Completed, Estimated PCD: 2022-08-31